PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
33466836-2	2021	In this study, farnesylthiosalicylic acid (FTS) was used to inhibit the activities of mutated KRAS in colon cancer SW480 cells to discover the potential link between KRAS activities and cancer-derived exosomes.	farnesylthiosalicylic acid	15-41	KRAS proto-oncogene, GTPase	Homo sapiens	94-98	
33466836-2	2021	In this study, farnesylthiosalicylic acid (FTS) was used to inhibit the activities of mutated KRAS in colon cancer SW480 cells to discover the potential link between KRAS activities and cancer-derived exosomes.	farnesylthiosalicylic acid	15-41	KRAS proto-oncogene, GTPase	Homo sapiens	166-170	
33466836-2	2021	In this study, farnesylthiosalicylic acid (FTS) was used to inhibit the activities of mutated KRAS in colon cancer SW480 cells to discover the potential link between KRAS activities and cancer-derived exosomes.	farnesylthiosalicylic acid	43-46	KRAS proto-oncogene, GTPase	Homo sapiens	94-98	
33466836-2	2021	In this study, farnesylthiosalicylic acid (FTS) was used to inhibit the activities of mutated KRAS in colon cancer SW480 cells to discover the potential link between KRAS activities and cancer-derived exosomes.	farnesylthiosalicylic acid	43-46	KRAS proto-oncogene, GTPase	Homo sapiens	166-170	
33466836-3	2021	We observed that FTS inhibits KRAS activity in SW480 cells, but promotes their exosome production.	farnesylthiosalicylic acid	17-20	KRAS proto-oncogene, GTPase	Homo sapiens	30-34